Rollins Financial 9 Meters Biopharma, Inc. Transaction History

Rollins Financial

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 01, 2022	SELL	$0.85 - $1.33 $8,500 - $13,300	-10,000 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$1.04 - $1.5 $10,400 - $15,000	10,000 New	10,000 $11,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Rollins Financial, based on Form 13F filings with the SEC.

Stay updated on Rollins Financial with notifications on news.